These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37147757)

  • 1. Effectiveness of Xiangsha Liujun pills on decreased digestive function in convalescent patients of coronavirus disease 2019: a randomized, double blind, placebo controlled clinical trial.
    Yuehong Z; Xianzhi S; Qianlong Z; Hualong Z; Jianhua Z; Sisi DU; Jing C; Yingfang L; Haiwang Z; Xinsheng C; Ying H; Fengmei L; Xiaolin T; Yuanming BA
    J Tradit Chin Med; 2023 Jun; 43(3):552-558. PubMed ID: 37147757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial.
    An X; Peng B; Huang X; Jiang H; Xiong Z; Zhang H; Lian F; Ba Y; Tong X
    Chin Med; 2022 Apr; 17(1):42. PubMed ID: 35366928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
    Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systematic review and Meta-analysis of efficacy and safety of Xiangsha Yangwei Pills in treatment of chronic gastritis].
    Zhang ZD; Liu H; Lyu J; Yu DD; Sun MH
    Zhongguo Zhong Yao Za Zhi; 2020 Jun; 45(11):2668-2676. PubMed ID: 32627502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study.
    Lv L; Wang FY; Ma XX; Li ZH; Huang SP; Shi ZH; Ji HJ; Bian LQ; Zhang BH; Chen T; Yin XL; Tang XD
    World J Gastroenterol; 2017 Aug; 23(30):5589-5601. PubMed ID: 28852318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.
    An X; Duan L; Zhang YH; Jin D; Zhao S; Zhou RR; Duan Y; Lian F; Tong X
    Chin Med; 2021 Jun; 16(1):44. PubMed ID: 34099015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial.
    Chen Y; Liu C; Wang T; Qi J; Jia X; Zeng X; Bai J; Lu W; Deng Y; Zhong B; He W; Xing Y; Lian Z; Zhou H; Yan J; Yang X; Yu H; Zhou J; Zhou D; Qiu L; Zhong N; Wang J
    J Ethnopharmacol; 2022 Feb; 284():114830. PubMed ID: 34763045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: A multicentre, double-blind, randomized controlled clinical trial.
    Chen HF; Gong Y; Huang Z; Zhao G; Chen ZM; Zen YM; Li HZ; Hu YL
    J Ethnopharmacol; 2022 Aug; 294():115341. PubMed ID: 35551978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.
    Xiao M; Tian J; Zhou Y; Xu X; Min X; Lv Y; Peng M; Zhang Y; Yan D; Lang S; Zhang Q; Fan A; Ke J; Li X; Liu B; Jiang M; Liu Q; Zhu J; Yang L; Zhu Z; Zeng K; Li C; Zheng Y; Wu H; Lin J; Lian F; Li X; Tong X
    Pharmacol Res; 2020 Nov; 161():105126. PubMed ID: 32781283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial.
    Shah MR; Fatima S; Khan SN; Shafiullah ; Azam Z; Shaikh H; Majid S; Chengdong H; Daijun Z; Wang W
    Front Pharmacol; 2024; 15():1293272. PubMed ID: 38440179
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial.
    Li W; Xie L; Zhu X; Yang Y; Wang L; Yang M; Li H; Li X; Yan G; Wu X; Zhao W; Zhang J; Yang G; Guo Y; Li C; Wang R; Shi L; Xiong Z; Xu P; Kong W; Cui M; Yang X; Ba Y
    Front Pharmacol; 2023; 14():1133560. PubMed ID: 37007028
    [No Abstract]   [Full Text] [Related]  

  • 18. Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial.
    Shah MR; Fatima S; Khan SN; Ullah S; Himani G; Wan K; Lin T; Lau JYN; Liu Q; Lam DSC
    Front Med (Lausanne); 2022; 9():928468. PubMed ID: 35979216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Yunchang Capsule in treatment of functional constipation: a randomized, double-blinded controlled, multicenter trial].
    Guo J; Zhang RM; Huang ZW; Wang L; Liu SS; Diao JC; Hu SY; Lin BH
    Zhong Xi Yi Jie He Xue Bao; 2009 Dec; 7(12):1123-9. PubMed ID: 20015431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.